Annual Drug Patent Expirations for TYZEKA Tyzeka is a drug marketed by Novartis and is included in two NDAs. There are three patents protecting this drug. This drug has fifty-five…
The post New patent expiration for Novartis drug TYZEKA appeared first …
This chart shows the pharmaceutical companies with the most patents in Sweden. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Sweden? Read Post »
Annual Drug Patent Expirations for IMVEXXY Imvexxy is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent for Therapeuticsmd Inc drug IMVEXXY appeared first o…
Annual Drug Patent Expirations for KALYDECO Kalydeco is a drug marketed by Vertex Pharms Inc and Vertex Pharms and is included in two NDAs. It is available from one supplier.…
The post New patent for Vertex Pharms drug KALYDECO appeared first on DrugPa…
Annual Drug Patent Expirations for POMALYST Pomalyst is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are eleven patents protecting…
The post New patent for Celgene drug POMALYST appeared first on DrugP…
This chart shows the pharmaceutical companies with the most patents in China. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug patent…
Which pharmaceutical companies have the most drug patents in China? Read Post »
Annual Drug Patent Expirations for UPNEEQ Upneeq is a drug marketed by Rvl Pharms and is included in one NDA. There are two patents protecting this drug. This drug has…
The post New patent for Rvl Pharms drug UPNEEQ appeared first on DrugPatentWatch – …
Annual Drug Patent Expirations for THALOMID Thalomid is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are nine patents protecting…
The post New patent expiration for Celgene drug THALOMID appeared first…
Annual Drug Patent Expirations for REVLIMID Revlimid is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are twenty patents protecting…
The post New patent expiration for Celgene drug REVLIMID appeared fir…
Annual Drug Patent Expirations for POMALYST Pomalyst is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are eleven patents protecting…
The post New patent expiration for Celgene drug POMALYST appeared fir…
Get new actionable insights and updates from BiotechBlog
